Whole Genome Sequencing Breakthrough for Cancer of Unknown Origin
Whole genome and transcriptome sequencing (WGTS) outperforms standard gene panels in diagnosing cancer of unknown origin, offering clearer tissue-of-origin insights and broader treatment options, according to new research.